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Introduction
‘it’s a bad drug it can kill and even its side effect(s) are 
very dangerous’. 
This was the comment of  an elderly nurse working in the 
pharmacy of  a local Christian Health Association of  Malawi 
(CHAM) facility when asked about oral morphine.  Is this 
what everyone thought? Is this what you think?
A qualitative study has recently been undertaken to investigate 
the beliefs, attitudes and practises of  clinicians, nurses and 
pharmacy staff  in the Southern Region of  Malawi towards 
the use of  oral morphine in the palliative care management 
of  HIV/AIDS and cancer. Data was gathered from fifteen 
interviews with different cadres of  health workers from five 
hospital sites.  In this paper we respond to some of  the issues 
raised by those who took part. In so doing we discuss the 
historical development of  morphine availability in Malawi 
and some of  the basic facts about the use of  oral morphine 
in pain management.
Background
Palliative care has been highlighted as an urgent need for 
patients with both HIV/AIDS and cancer in sub-Saharan 
Africa1,2. More recently palliative care has been proposed as 
a basic human right3,4. The London declaration on Cancer 
Control in Africa in 2007 stated that ‘African countries will 
account for over a million cases of  cancer per year’5 with 
an estimated eighty eight to ninety five percent of  patients 
presenting at a late or end stage of  disease.6 The mainstay of  
management for many patients with cancer from the time 
of  diagnosis thus requires a palliative approach with optimal 
pain and symptom control.  Twelve percent of  15-49 year 
olds in Malawi out of  a total population of  around thirteen 
and a half  million are infected with HIV, and around sixty 
one thousand deaths per year are attributable to AIDS.7 In 
HIV pain occurs as a result of  a variety of  factors: from HIV 
itself, from opportunistic infections and as a result of  the side 
effects of  antiretroviral (ARV) medication. Pain in patients 
with HIV/AIDS is often underdiagnosed and undertreated8. 
Timely attention to pain and symptom control will help to 
improve long term adherence for those taking ARVs. 
Central to the WHO definition of  palliative care is the ‘early 
identification and impeccable assessment and treatment of  
pain…’9 Morphine is recommended by the WHO as the 
drug of  choice for severe pain in cancer. Between January 
and December 2006 fifty one percent of  the two hundred 
and twenty eight patients referred to the adult palliative care 
service at Queen Elizabeth Central Hospital received oral 
morphine to control symptoms (either pain or shortness of  
breath)10. The WHO analgesic ladder (page 129), which was 
initially developed in 1986, has been shown to control pain 
in over seventy five per cent of  patients with cancer11. These 
guidelines have been recommended for pain management 
in other conditions including HIV/AIDS12. The analgesic 
ladder is part of  Ministry of  Health management guidelines 
in Malawi.13
What did health workers say about oral 
morphine?
‘it would be important for the medication to be available 
to all hospitals’ 
In Africa advocacy for availability of  pain relieving drugs 
has accelerated under the leadership of  the African Palliative 
Care Association with the backing of  several high profile 
international donors.  As part of  these advocacy efforts, 
APCA has hosted a series of  regional drug availability 
workshops across the continent.  In June 2006 a high level 
delegation from Malawi attended the first regional workshop 
in Entebbe, Uganda, identifying three key areas affecting 
morphine supply in the country : firstly the poor supply of  
liquid morphine, secondly, poor data collection and reporting 
systems by health facilities and thirdly, patients’ limited 
accessibility to morphine.
‘sometimes it’s there but sometimes it is not available like 
right now we don’t have it’ 
In Malawi, morphine is listed as a high priority, vital drug 
in the Essential Health Package Medicines and Supplies 
list14. Between 1990 and 2007, the International Narcotics 
Control Board (INCB) received only one annual report 
on morphine use from Malawi15. Following the inclusion 
of  a chapter on palliative care in the Ministry of  Health 
guidelines ‘Management of  HIV related Diseases’ in 2004, 
morphine (as MST slow release 10 mg tablets) has been 
supplied free of  charge to all hospitals in Malawi which 
deliver antiretroviral drugs as part of  a package of  care and 
support funded through the Global Fund.  National supply 
of  MST has been out of  stock from 2006 and – due to 
lack of  adequate routine reporting to the INCB – further 
morphine could not be imported in 2007 as the national 
import quota ceiling had been reached.  Oral morphine 
solution (an immediate release, short acting preparation of  
morphine) has also been available through the Lighthouse 
Trust in Lilongwe for use at a limited number of  sites where 
palliative care teams have developed.  Reporting to the INCB 
has been restarted as of  2007, with the Ministry of  Health 
handing over its responsibility as the national statutory body 
to the Pharmacy, Medicines and Poisons Board (PMPB).  The 
quota for morphine has recently been increased.  Licenses 
for the purchase and import of  morphine are available by 
application to the PMPB.
‘It should be available even at their homes, they should 
be able to take the medicine home or even here at the 
hospital the process of collecting it should not be too 
tedious and difficult’
Review of  the home based care policy document 
reveals mention of  the need for ‘palliative care including 
psychosocial and spiritual care’ but does not specifically 
emphasise the need for adequate pain relief  as part of  the 
package of  services for community care16. Only step one 
analgesics (paracetamol, aspirin and diclofenac) of  the 
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WHO three step analgesic ladder are listed for inclusion in 
the home based care supervisor’s kit.  Review of  community 
based services in other African countries also highlights the 
problem of  limited access to oral morphine through home 
based care programmes10.  The Uganda model of  public 
health expansion to improve access to morphine has shown 
that oral morphine can be safely and effectively delivered at 
community level17.  Learning from the Ugandan experience 
(which uses mobile services run by specially qualified nurse 
prescribers able to assess pain and provide oral morphine 
liquid where necessary) is critical considering that the vast 
majority of  the population of  Malawi live in rural areas, 
often far away from their nearest health facility.
‘the general thinking (is) that probably he is going to 
become addicted’
The production, processing and distribution of  morphine 
is carefully controlled and regulated by the INCB  in 
collaboration with national governments in order to 
minimise the risk of  diversion for use by drug addicts.  A 
survey of  palliative care users of  oral morphine in India 
found no instances of  misuse or diversion of  opiates, 
despite the fears of  the authorities18.  The INCB, the World 
Health Assembly and other international bodies have noted 
that, whilst stringent controls are adhered to, the obligation 
to promote access to opiates for medical purposes is often 
neglected.  Statistics show that developing countries - with 
eighty percent of  the world’s population - consume only six 
percent of  the world’s supply of  morphine19. 
‘I know several workers who are addicted; one is addicted 
to pethidine and the other valium’
Poor understanding of  the terms addiction, physical 
dependence and tolerance present barriers to optimal opiate 
prescribing.  Glajchen reports the National Federation of  
State Medical Boards definition of  addiction as ‘psychological 
dependence on the use of  substances for their psychic effects, 
characterised by compulsive use despite harm’20.  This is in 
contrast with physical dependence where gradual reduction 
of  an established opiate dose is required to avoid symptoms 
of  withdrawal  which does occur with opiate medication. 
However this phenomenon is similar to that found with 
other long term medications such as corticosteroids.  In a 
recent letter to the Lancet, Nigel Sykes from St Christopher’s 
Hospice in London calls for physicians to move on from their 
‘opiophobic’ attitudes21.  Despite being a frequent concern 
expressed during our study, none of  those interviewed 
were able to report or recall any actual cases of  addiction to 
support their fears.  This is reflected in the literature which 
reports negligible or no opiate abuse or diversion when 
opiates are made available for palliative care patients in both 
African and other settings22-24.  
‘most of my patient(s) when I start morphine I know 
that the chance of them being addicted is low because 
some of them are terminal…even if they came addicted 
when they are about to die it’s ok’
‘Strong opioids exist to be given, not merely to be withheld; 
their use should be dictated by therapeutic need and response, 
not by brevity of  prognosis.’25  At the heart of  the WHO 
definition of  palliative care is the stated aim to prevent and 
relieve suffering by ‘the early identification and impeccable 
assessment of  pain and other symptoms…’7, thus morphine 
should not be reserved only for ‘terminal cases’.  Morphine 
is approximately ten times stronger than codeine and has 
no ceiling effect. It can be titrated upwards from the initial 
starting dose as necessary to control symptoms, so long as 
side effects (predominantly constipation) do not become 
intolerable. 
‘he (or she) says its only going to work if you give me 
morphine so next time they come and you give them (an) 
injection which they think its pethidine they feel good so 
that is the issue’
Confusion exists between pethidine and oral morphine.  In 
fact pethidine is no longer recommended for the treatment of  
pain in many settings, whether acute or chronic26.  This is for 
a number of  reasons, it is short acting, has to be administered 
intramuscularly (which maybe painful for the patient), and has 
a less favourable side effect profile than morphine.  If  used 
repeatedly metabolites accumulate resulting in a reduction in 
seizure threshold.  A report prepared by the Pain and Policy 
Studies Group for the APCA Regional Advocacy workshop 
for Palliative care in Africa mentions that, despite this, 
pethidine is still widely used13.
‘the main side effect is constipation…so we usually 
prescribe a laxative as well’
This is correct, and in Malawi bisacodyl 10mg at night is 
commonly started concurrently with oral morphine unless 
the patient has pre-existing diarrhoea.  Other side effects 
include initial drowsiness, particularly in opiate naïve patients, 
who should be warned of  this, but encouraged that it will 
improve after the first day or two.  Starting patients at low 
doses (for oral morphine liquid 2.5mg every four hours, for 
MST tablets 10mg twice daily) and titrating upwards until 
pain is controlled also reduces the risk of  unnecessary side 
effects (including respiratory depression).  Patients may get 
a dry mouth and occasionally itching though this is more 
common when morphine is administered parenterally or via 
epidural.  Nausea and vomiting are rare as side effects in 
African patients27. 
‘I feel it would be helpful if you gave us maybe some form 
of a talk or a course on what type of patients we should 
prescribe morphine (for). Each clinician here prescribes 
based on personal judgement’
The Palliative Care Association of  Malawi was registered in 
2006.  It has been working in partnership with the Ministry 
of  Health to promote, develop and support access to 
affordable and culturally appropriate palliative care through 
advocacy, training and technical support. As a result, a five day 
introductory training course for health care workers has been 
established.  Around five hundred people have completed 
this training that includes modules on pain assessment, pain 
management, and the safe and appropriate use of  morphine. 
The national association also arranges clinical attachments so 
that health professionals who have undergone the course can 
gain hands on experience in prescribing oral morphine and 
other medications needed for pain and symptom control. 
Summary and conclusions 
According to the WHO analgesic ladder medication should 
be given ‘by mouth, by the clock, and by the ladder’ with 
dose titration upwards until pain is adequately controlled28. 
Effective pain relief  has been identified by patients and 
Morphine: friend or foe? 114
MMJ 20(4) 2008 www.mmj.medcol.mw
families affected by HIV/AIDS  as a main priority to 
improve their quality of  life10, and this priority is central 
to palliative care. Currently Malawi has limited oncology 
services, particularly for adults, many of  whom present in 
the late stages of  disease. 
 Physical dependence to long term opiates may occur but 
this is true of  other medications such as antihypertensive 
medication. Physical dependence should not be confused with 
the psychological craving which characterizes addiction.
Morphine is naturally occurring and cheap to manufacture. It 
should be considered as a ‘friend’ and not a ‘foe’.  All clinicians, 
nurses and pharmacy staff  in Malawi need to be educated 
and supported in effective prescription, administration and 
dispensing of  oral morphine in order that - in the words of  
Dame Cicely Saunders (the founder of  the modern hospice 
palliative care movement) - we ‘do all that we can…to help 
you live until you die’29.
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